PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO...

Value in Health 2019 / 05 Vol. 22

PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC

Dolezel, J., Havrdova, E.K., Skalicky, D., Pour, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1341
Date:
May, 2019
File:
PDF, 382 KB
english, 2019
Conversion to is in progress
Conversion to is failed